{"name":"Bharat Biotech International Limited","slug":"bharat-biotech-international-limited","ticker":"","exchange":"","domain":"bharatbiotech.com","description":"","hq":"Hyderabad","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"immunology","drugs":[{"name":"BBV152A - Phase I","genericName":"BBV152A - Phase I","slug":"bbv152a-phase-i","indication":"Other","status":"phase_1"},{"name":"ORV 116E","genericName":"ORV 116E","slug":"orv-116e","indication":"Prevention of rotavirus gastroenteritis in infants and children","status":"phase_3"},{"name":"Covishield","genericName":"Covishield","slug":"covishield","indication":"Other","status":"phase_3"},{"name":"ROTAVAC 5C -F1","genericName":"ROTAVAC 5C -F1","slug":"rotavac-5c-f1","indication":"Prevention of rotavirus gastroenteritis in infants and young children","status":"phase_3"},{"name":"ROTAVAC 5C -F2","genericName":"ROTAVAC 5C -F2","slug":"rotavac-5c-f2","indication":"Prevention of severe rotavirus gastroenteritis in infants and young children","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Intramuscular vaccine COVAXIN","genericName":"Intramuscular vaccine COVAXIN","slug":"intramuscular-vaccine-covaxin","indication":"COVID-19 prevention in adults and children","status":"phase_3"},{"name":"THR-100","genericName":"THR-100","slug":"thr-100","indication":"Prevention of COVID-19 disease","status":"phase_3"},{"name":"BBV154 Intranasal Vaccine","genericName":"BBV154 Intranasal Vaccine","slug":"bbv154-intranasal-vaccine","indication":"COVID-19 prevention (intranasal booster or primary series)","status":"phase_3"},{"name":"BBV154(Intranasal) & covaxin","genericName":"BBV154(Intranasal) & covaxin","slug":"bbv154-intranasal-covaxin","indication":"COVID-19 prevention as a booster dose in Covaxin-primed individuals","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Hillchol vaccine","genericName":"Hillchol vaccine","slug":"hillchol-vaccine","indication":"Cardiovascular disease prevention / atherosclerosis risk reduction","status":"phase_3"}]}],"pipeline":[{"name":"Intramuscular vaccine COVAXIN","genericName":"Intramuscular vaccine COVAXIN","slug":"intramuscular-vaccine-covaxin","phase":"phase_3","mechanism":"COVAXIN is an inactivated whole-virus COVID-19 vaccine that stimulates immune responses against SARS-CoV-2 through presentation of viral antigens.","indications":["COVID-19 prevention in adults and children"],"catalyst":""},{"name":"THR-100","genericName":"THR-100","slug":"thr-100","phase":"phase_3","mechanism":"THR-100 is a recombinant human monoclonal antibody that targets the SARS-CoV-2 spike protein.","indications":["Prevention of COVID-19 disease"],"catalyst":""},{"name":"BBV152A - Phase I","genericName":"BBV152A - Phase I","slug":"bbv152a-phase-i","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"BBV154 Intranasal Vaccine","genericName":"BBV154 Intranasal Vaccine","slug":"bbv154-intranasal-vaccine","phase":"phase_3","mechanism":"BBV154 is an intranasal recombinant vaccine that stimulates mucosal and systemic immune responses against SARS-CoV-2 by delivering viral antigens directly to respiratory tract tissues.","indications":["COVID-19 prevention (intranasal booster or primary series)"],"catalyst":""},{"name":"Hillchol vaccine","genericName":"Hillchol vaccine","slug":"hillchol-vaccine","phase":"phase_3","mechanism":"Hillchol is a therapeutic vaccine designed to induce immune responses against cholesterol and lipid-related antigens to reduce cardiovascular risk.","indications":["Cardiovascular disease prevention / atherosclerosis risk reduction"],"catalyst":""},{"name":"ORV 116E","genericName":"ORV 116E","slug":"orv-116e","phase":"phase_3","mechanism":"ORV 116E is an oral rotavirus vaccine candidate designed to provide immunization against rotavirus infection.","indications":["Prevention of rotavirus gastroenteritis in infants and children"],"catalyst":""},{"name":"BBV154(Intranasal) & covaxin","genericName":"BBV154(Intranasal) & covaxin","slug":"bbv154-intranasal-covaxin","phase":"phase_3","mechanism":"BBV154 is an intranasal booster vaccine designed to enhance immune response against SARS-CoV-2 when administered after Covaxin (inactivated COVID-19 vaccine) priming.","indications":["COVID-19 prevention as a booster dose in Covaxin-primed individuals"],"catalyst":""},{"name":"Covishield","genericName":"Covishield","slug":"covishield","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ROTAVAC 5C -F1","genericName":"ROTAVAC 5C -F1","slug":"rotavac-5c-f1","phase":"phase_3","mechanism":"ROTAVAC 5C-F1 is a live attenuated rotavirus vaccine that stimulates immune responses against rotavirus to prevent gastroenteritis.","indications":["Prevention of rotavirus gastroenteritis in infants and young children"],"catalyst":""},{"name":"ROTAVAC 5C -F2","genericName":"ROTAVAC 5C -F2","slug":"rotavac-5c-f2","phase":"phase_3","mechanism":"ROTAVAC 5C -F2 is a vaccine that protects against rotavirus infection.","indications":["Prevention of severe rotavirus gastroenteritis in infants and young children"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-12-26","type":"pipeline","source":"Indian Pharma Post","summary":"Biofabri and Bharat Biotech ink tech transfer pact to boost global TB vaccine access - Indian Pharma Post","headline":"Biofabri and Bharat Biotech ink tech transfer pact to boost global TB vaccine access","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-23","type":"deal","source":"Medical Dialogues","summary":"Bharat Biotech, Biofabri ink technology transfer deal for TB vaccine MTBVAC - Medical Dialogues","headline":"Bharat Biotech, Biofabri ink technology transfer deal for TB vaccine MTBVAC","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-22","type":"pipeline","source":"ET Pharma","summary":"Bharat Biotech, Biofabri ink tech transfer agreement for late-stage TB vaccine - ET Pharma","headline":"Bharat Biotech, Biofabri ink tech transfer agreement for late-stage TB vaccine","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-10","type":"deal","source":"Medical Dialogues","summary":"Bharat Biotech, Aurobindo and Hetero sign multi crore investment deals in Telangana - Medical Dialogues","headline":"Bharat Biotech, Aurobindo and Hetero sign multi crore investment deals in Telangana","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-04","type":"pipeline","source":"Medical Dialogues","summary":"Bharat Biotech unveils Cell and Gene Therapy CRDMO - Nucelion - Medical Dialogues","headline":"Bharat Biotech unveils Cell and Gene Therapy CRDMO - Nucelion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQUVdpVktlSmhJMzlQQVdRc25ROEVhekdKa25sd2JZSWVxbFVGZUE2amZlQ1JXZmV3d2tTYnQyR1AydFI5TzY1S0NqTmJVMVR3MXN2Q1l6c0VzOWdZbHIxMDgxdFpWd01EazR2cFFOdmZUMFBzU21fUTBKR01zdHVWdVdaUkFIV0pIc0sxZ201cUdJV3BaeWxHWjd4a1BYcURkOEp2VEI4ak1RdzdWU29WbHpfT0t2TzJmNFQtN1JDdmVNSGFHYWUxVlRubFZ5NTkyVld1RFJkV0VyNjUwRjhWdA?oc=5","date":"2025-11-03","type":"pipeline","source":"scanx.trade","summary":"Bharat Biotech Expands into Cell & Gene Therapy with Launch of Nucelion Therapeutics - scanx.trade","headline":"Bharat Biotech Expands into Cell & Gene Therapy with Launch of Nucelion Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNUUFfbnI3cmNUSkMxY3FfSjIzOVZabENDTndjQ202Q19wZUtZOUQ4Y1R5dUlpTHZ0dDUyeEdmNkhGd3dUX3NzX3lqU0UwZXQ5azQ2RGw3VW94YTdDN2dtQnZqdkd6Tk9TT2VldkI4NmtMZFRoaURNWUVhb25sa09oY2F2enhzV0d4ZWQxWDhYN1E4clF5ZThGY1lqRVY2N1lYQjd4SGNnbW03elZyQVA4QjZsU0dYY3dHN0ZyYVczdw?oc=5","date":"2025-11-03","type":"pipeline","source":"BioSpectrum India","summary":"Bharat Biotech launches Next-Gen Cell and Gene Therapy CRDMO Nucelion - BioSpectrum India","headline":"Bharat Biotech launches Next-Gen Cell and Gene Therapy CRDMO Nucelion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQMG1ELUM3ZjZXbVpMcTBNQTVHdUNVXzJLSDdZc1hxN0N0LU5KNWxwcS1mX2V0SEdMeF94MGhIZVA4WGxrMFM2SUxDMDhiR1lLdmpteEhKYzNCZmVKUVlEVVBJaVM3V2FyWEl4MTNEVG9RQVI0V3NWZ0xXbDBQNzB1dUpuRXRKZm56UXNKNzlIcUVnaDJBcWY4Y2ZSMng?oc=5","date":"2025-06-27","type":"pipeline","source":"The Indian Practitioner","summary":"Bharat Biotech and GSK to Halve Malaria Vaccine Price by 2028 | - The Indian Practitioner","headline":"Bharat Biotech and GSK to Halve Malaria Vaccine Price by 2028 |","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQcGZPZFRWMVJ3X1JiV2tVME1ndF9WYndDWVNNSXRHb3lzV0NaZ2M0dHNmd2pVbGpPSkp2SllpV002cHF3NFNjbDZnbkxNN3czaVQwdDlmVC1aX0J6aV9KZXY3NnhQcjJIeC1zT3NVcVV2SHZaX0UyZ0VuU0s5VkxmeHAxaS1rOUJ0QXowNmRLTFhkWlF6a0tiM3pHNkNlcDdqUGc?oc=5","date":"2025-06-25","type":"pipeline","source":"Fierce Pharma","summary":"GSK, Bharat Biotech to slash the price of first malaria vaccine to less than $5 per dose by 2028 - Fierce Pharma","headline":"GSK, Bharat Biotech to slash the price of first malaria vaccine to less than $5 per dose by 2028","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2025-05-21","type":"trial","source":"The Economic Times","summary":"Bharat Biotech's cholera vaccine successfully completes Phase-III trials - The Economic Times","headline":"Bharat Biotech's cholera vaccine successfully completes Phase-III trials","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxOVjY2QTZkVHhVci1KbnpZS19jM0pfY2YzTlF4QlU4UFp3Z09oZ3NNSHBlR1hub0JtZzR4VkdqQm1tS0RHSURyVUhCT1EzaElfOUpfQklFeEduVTA5NG5qUVhOdTY2SWgzTkRIT2tLTzYzZkluS1JqcGdhX3NoSHpYWWFtc1BfWWt5Z2g1TE05cEhfa1lFVlFaVzRfbzZHcXFPZmxnSVBPaXFMVmdCcXRpNndZZEl2aGlwX0xLOFAtcFA4RTZ4SEIya3RnNGxURW5abjF2NC1fY0RXUG5VMkhJd3B3?oc=5","date":"2024-08-27","type":"pipeline","source":"Reuters","summary":"India's Bharat Biotech to launch oral cholera vaccine amid global shortage - Reuters","headline":"India's Bharat Biotech to launch oral cholera vaccine amid global shortage","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPWjAtQ3FtMHRzYjJRei0wOUlfbVR6eGNWRzl0ZDNlSDRkUnBkT21TR09LekV2eHJWcmVtVFY1VVNuNUJNZGtuU2RJVGdGeHpYWS1vNUFGWWYyZ1VMa2VFT21lN2czakUyc1FjUlFEZk5jZEFhUVQ3bkE4RGZWSFdHYzEzbHpuT2VNT25tZDl4NUFmenlCaHFXQmJFQ3M?oc=5","date":"2021-11-22","type":"pipeline","source":"PharmaTimes","summary":"UK recognises Covaxin as valid COVID-19 vaccine for travel - PharmaTimes","headline":"UK recognises Covaxin as valid COVID-19 vaccine for travel","sentiment":"neutral"}],"patents":[],"drugCount":10,"phaseCounts":{"phase_3":9,"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}